Latest news about signalling science and CIBSS scientists
Actin scaffold in cell nucleus explains survival of cancer cells
Researchers from the Cluster of Excellence CIBSS have demonstrated that an actin scaffold stabilizes the cell nucleus upon mechanical stress. This protective mechanism helps cancer cells to avoid dying during their migration in the body. In the long term, targeted interventions in this mechanism could help to prevent metastases.
More
Growth switch for adaptability of plants discovered
Researchers from Freiburg have discovered a mechanism by which plant hormones are specifically regulated in order to adapt growth to environmental conditions - controlled by the so-called ERAD machinery. The study has been published in the journal Science Advances. The results could help to make crops more resilient in the future and thus make agriculture more sustainable.
More
New leadership team for CIBSS
Sonja-Verena Albers joins as new spokesperson – Claudine Kraft officially confirmed in her role
More
New podcast episode online: Balancing the immune system
In the podcast ‘Exzellent erklärt’ (excellent explanation), scientists from the Freiburg Cluster of Excellence CIBSS talk about their research into biological signals and their application
More
Ultra-fast brain speed; New findings on calcium transport and signal processing
Two studies involving the University of Freiburg are expanding fundamental knowledge of signal processing in the brain and opening up new approaches for drugs - for example against hereditary deafness.
More
Shaping the Future Together: UniWerk Is the winning project of the Freiburg Unicorn Fund
A mobile participation format prevails in the University’s Unicorn Fund initiative. UniWerk was selected as the winner from among 35 strong ideas. As part of Freiburg’s proposal in the Excellence Strategy, it could provide impetus for innovation and transformation across the University from 2027 on.
More
New therapeutic approach for rare childhood brain disease
Freiburg physicians show for the first time that immune cells in the brain are involved in the disposal of metabolic products
More
Taking the fight against colorectal cancer from the lab to a start-up
If you combine top-level research and entrepreneurial spirit, you can generate positive effects for society and business. That’s the premise of the University of Freiburg spin-off EMUNO Therapeutics GmbH, founded by Dr. Emilia Neuwirt and Prof. Dr. Olaf Groß.
More
Targeted activation of brain immune cells delays Alzheimer's processes
Study in an animal model shows how the brain's own immune cells react in Alzheimer's disease. Freiburg researchers identify an important signaling pathway. The study was published in Nature Neuroscience.
More
Molecular arms race: How the genome defends itself against internal enemies
An international research team has deciphered a mechanism of evolutionary arms race in human cells.
More